"Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the Real-life : Result of the French Experience in 72 Adults"

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

August 31, 2009

Conditions
Thrombopenia
Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

collaborator

Paris 12 Val de Marne University

OTHER

lead

Henri Mondor University Hospital

OTHER